Fremanezumab
Indication
Fremanezumab for preventing migraine (NICE TA764)
Red
Brand:
Nice TA:
764
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Central nervous system
Background
1.1 Fremanezumab is recommended as an option for preventing migraine in adults, only if:
-
they have 4 or more migraine days a month
-
at least 3 preventive drug treatments have failed and
-
the company provides it according to the commercial arrangement.